Rosemont Pharmaceuticals
Grant McKechnie is a seasoned professional in quality assurance and project management within the pharmaceutical and healthcare sectors. Currently serving as a Quality Auditor at Rosemont Pharmaceuticals since March 2021, Grant brings extensive experience from previous roles, including Senior Supplier Management Engineer at Kindeva Drug Delivery, where expertise in supplier management and ISO auditing was demonstrated, and Senior Manufacturing Technology Engineer at 3M Health Care, focusing on project management of new products and processes. Grant's background also includes significant roles as Senior Project Manager at Piramal Enterprises Limited and Operations Manager at AstraZeneca, with a strong emphasis on compliance and regulatory standards. Earlier career experience includes management at Rentokil Initial, further showcasing a solid foundation in operational leadership. Grant completed education at Glasgow Caledonian University from 1977 to 1979.
Rosemont Pharmaceuticals
At Rosemont our mission is to be a rapid developer, reliable manufacturer and global supplier of novel-delivery, patient-focused medicines. Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practice for the care of patients with swallowing difficulties. Rosemont advocate the use of liquid medication over manipulating solid dose medications and we have a range of educational materials designed for healthcare professionals which focuses on key patient groups and their medication management challenges. At Rosemont we have a portfolio of over 130 oral liquid medicines across a range of therapeutic areas including 70 licensed products. All of our products, both licensed and ‘specials’ are made to the same exacting standards under GMP. Our UK range also includes 9 products licensed for use with PEG/NG tubes. We are always seeking to expand our range of medicines and covert our ‘specials’ to licensed product wherever possible.